Introduction {#s1}
============

Ribosomes terminate translation when release factors (RFs) recognize an mRNA stop codon in the A ([a]{.ul}minoacyl-tRNA) site ([@bib12]; [@bib11]). Upon stop-codon recognition, the release factor hydrolyzes [p]{.ul}eptidyl-tRNA in the P site of the large subunit, thus releasing nascent protein from the ribosome ([@bib17]; [@bib18]; [@bib90]; [@bib100]). In bacteria, RF1 recognizes UAA or UAG, and RF2 recognizes UAA or UGA codons ([@bib69]). Following peptide release, RF1 or RF2 must dissociate from the ribosome to allow the ribosome and release factor to recycle. While structural studies have provided snapshots of some peptidyl-tRNA hydrolysis steps (reviewed in [@bib28]; [@bib55]; [@bib82]; [@bib86]; [@bib105]), recent biophysical and biochemical findings suggest a highly dynamic series of termination events ([@bib4]; [@bib44]; [@bib80]; [@bib94]), which have not been structurally visualized.

In the pre-termination (pre-hydrolysis) state, the substrate peptidyl-tRNA resides in a non-rotated (classical) conformation of 70S ribosome, with its anticodon stem loop bound to the mRNA codon in the P site of the small 30S subunit and the 3′-terminal CCA-peptidyl moiety in the P site of the large 50S subunit ([@bib7]; [@bib29]). Cryogenic electron microscopy (cryo-EM) and X-ray studies reveal RF1 or RF2 bound in the A site next to P tRNA ([@bib50]; [@bib75]; [@bib85]; [@bib84]), and provide insight into pre-hydrolysis ([@bib47]) and post-hydrolysis states ([@bib53]; [@bib54]; [@bib60]; [@bib104]). The release factor's codon-recognition domain (domain 2) binds the stop codon in the 30S decoding center. The catalytic GGQ motif (glycine-glycine-glutamine of domain 3) inserts into the 50S peptidyl-transferase center (PTC) adjacent to the CCA end of P-tRNA. Ribosomes retain the non-rotated conformation in RF-bound structures, including those with mutated or post-translationally modified RFs ([@bib77]; [@bib87]; [@bib107]) or when RFs are perturbed by the termination inhibitor blasticidin S ([@bib98]; [@bib99]) or by a sense codon in the A site ([@bib97]). The catalytic GGQ loop adopts the same compact conformation comprising a short α-helix in pre-hydrolysis-like and post-hydrolysis structures, as discussed below.

Ribosome and RF dynamics are implicated in post-hydrolysis steps. In *E. coli*, RF1 dissociation is assisted by the non-essential GTPase RF3 ([@bib33]; [@bib56]), whereas RF2 can spontaneously dissociate from the ribosome ([@bib4]). RF3 induces rotation of the small subunit relative to the large subunit by \~9 degrees in the absence of RF1 and RF2 ([@bib29]; [@bib108]) and stabilizes a 'hybrid' state of deacylated tRNA (P/E) ([@bib36]; [@bib48]). In the P/E conformation, the anticodon stem loop remains in the 30SS P site, while the elbow and acceptor arm bind the L1 stalk and E ([e]{.ul}xit) site of the 50S subunit. A recent cryo-EM study ([@bib38]) showed that if RF1 is locked on the post-hydrolysis ribosome by antibacterial peptide apidaecin 137 ([@bib31]), the ribosome can undergo intersubunit rotation in the presence of both RF1 and RF3. By contrast, biochemical experiments showed that locking RF1 on the ribosome by inactivating its catalytic motif (GGQ-\>GAQ) prevented RF1 recycling by RF3 from the pre-hydrolysis ribosome ([@bib56]), echoing the deficiency of mutant RF2 (GGQ-\>GAQ) in stimulating GTP hydrolysis by RF3 ([@bib106]). These and other ([@bib4]) observations indicate that peptidyl-tRNA hydrolysis is critical for RF dissociation, likely due to propensity of deacylated tRNA for exiting the P site and sampling the P/E hybrid state ([@bib68]) via spontaneous intersubunit rotation ([@bib23]). Nevertheless, RF3 is dispensable for growth of *Escherichia coli* ([@bib40]; [@bib67]), and its expression is not conserved in bacteria ([@bib61]). For example, RF3 is not present in the thermophilic model organisms of the *Thermus* and *Thermatoga* genera and in infectious *Chlamydiales* and *Spirochaetae*. This means that both RF1 and RF2 are capable of performing a complete round of termination independently of RF3. Indeed, recent Förster Resonance Energy Transfer (FRET) studies demonstrate spontaneous RF1 and RF2 dissociation after peptidyl-tRNA hydrolysis ([@bib80]), coupled with transient RF sampling of the rotated ribosomes ([@bib4]). The structural basis for RF dissociation, however, remains incompletely understood because RFs have not been structurally visualized on ribosomes with rearranged/rotated subunits in the absence of RF3 and inhibitors.

In this work, we used ensemble cryo-EM, as described earlier ([@bib1]; [@bib63]), employing 3D maximum likelihood classification/sorting of particle images ([@bib65]; [@bib89]; [@bib88]) to visualize the structural dynamics of RF2 on the 70S ribosome ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The structures capture RF2 and tRNA in distinct 70S conformational states ([Table 1](#table1){ref-type="table"}). They reveal an unexpected rearrangement of the catalytic GGQ loop, which suggests that RF2 helps direct nascent protein out of the ribosome. Our findings reconcile biophysical observations and, together with other structural studies, allow a reconstruction of the termination course by RF2, from initial binding to dissociation.

![Cryo-EM Structures I to V.\
Panels A-E show for each structure: *upper row:* a schematic of the conformations of the 70S ribosome, tRNA and RF2, with ribosomal subunits (50S and 30S) and A, P and E sites labeled; *middle row:* structures with RF2 shown in red, tRNA^fMet^ in orange, 30S subunit in yellow, 50S subunit in cyan and mRNA in purple; *lower row:* cryo-EM density for mRNA, tRNA and RF2, colored as in the middle row. Domains of RF2 are labeled in panel B, illustrating the codon-recognition superdomain (domains 2 and 4) and catalytic domain (3).](elife-46850-fig1){#fig1}
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###### Cryo-EM structures obtained from a single sample of the 70S•RF2 complex.

  -------------------------------------------------------------------------------------------------------------
                               **I**    **II**     **III**                 **IV**                    **V**
  ---------------------------- -------- ---------- ----------------------- ------------------------- ----------
  tRNA and RF2 occupancy       P-tRNA   P-tRNA,\   P-like (L5) tRNA, RF2   P/E-like (L1) tRNA, RF2   P/E tRNA
                                        RF2                                                          

  30S (body) rotation          1.6°     1.6°       4.9°                    7.4°                      6.8°

  30S head rotation (swivel)   2.0°     1.4°       1.7°                    2.8°                      6.0°

  Resolution (FSC = 0.143)     3.3 Å    3.3 Å      3.7 Å                   4.4 Å                     3.4 Å
  -------------------------------------------------------------------------------------------------------------

Results and discussion {#s2}
======================

We formed a termination complex using *E. coli* 70S ribosomes and RF2 to catalyze the hydrolysis of substrate N-formyl-methionyl-tRNA^fMet^ (fMet-tRNA^fMet^) bound to mRNA carrying an AUG codon in the P site and a UGA stop codon in the A site. Although the stop codon is placed immediately after the start codon, unlike in cellular mRNAs, such model termination complexes have been successfully used in numerous structural, biochemical and biophysical studies ([@bib4]; [@bib19]; [@bib56]; [@bib58]; [@bib60]; [@bib74]; [@bib77]; [@bib92]; [@bib94]). Indeed, under the conditions used for cryo-EM sample preparation in this work, RF2 supports hydrolysis of fMet-tRNA^fMet^ and release of fMet ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}), demonstrating activity of the ribosome and RF2 in our sample. Maximum-likelihood classification of cryo-EM data in FREALIGN ([@bib65]) yielded five structures at average resolutions of 3.3 Å to 4.4 Å ([Table 2](#table2){ref-type="table"}; [Figure 1](#fig1){ref-type="fig"}). The structures differ by the degrees of intersubunit rotation and 30S head rotation (swivel), and are consistent with the following termination stages: pre-termination (i.e., no RF2; Structure I); peptidyl-tRNA hydrolysis by RF2 (Structure II); tRNA exit from the PTC (Structure III); destabilization of the catalytic domain of RF2 (Structure IV); and post-termination (i.e., after RF2 dissociates; Structure V).

10.7554/eLife.46850.008

###### Data collection and refinement statistics for cryo-EM Structures I-V.

  ----------------------------------------------------------------------------------------------
  STRUCTURE                                 I                 II       III      IV      V
  ----------------------------------------- ----------------- -------- -------- ------- --------
  PDB ID\                                   6OFX\             6OG7\    6OGF\    6OGG\   6OGI\
  EMD code                                  20048             20052    20056    20057   20058

  Data collection                                                                       

  EM equipment                              FEI Titan Krios                             

  Voltage (kV)                              300                                         

  Detector                                  K2 summit                                   

  Pixel size (Å)                            1.33                                        

  Electron dose (e^-^/Å^2^)                 29.4                                        

  Defocus range (μm)                        -- 0.5 -- 1.8                               

  Reconstruction                                                                        

  Software                                  Frealign v9.11                              

  Number of particles in final map          102,723           62,029   28,549   5,881   63,383

  Final resolution (Å)                      3.3               3.3      3.7      4.4     3.4

  Average sharpening *B* factor (Å^2^)      -30               -26      -17      -4      -30

  Structure Refinement                                                                  

  Model Fitting                             Chimera/Pymol                               

  Refinement                                                                            

  Software                                  RSRef/Phenix                                

  Correlation Coefficient,cc_mask^**\***^   0.83              0.84     0.84     0.76    0.82

  Real-space R-factor ^†^                   0.25              0.23     0.22     0.25    0.25

  Validation (proteins)                                                                 

  MolProbity Score ^‡^                      2.22              2.34     2.42     2.26    2.24

  Clash score, all atoms ^‡^                17.4              17.4     16.5     15.1    16.3

  Poor rotamers (%) ^‡^                     0.4               0.7      0.7      0.6     0.5

  Favored/allowed rotamers (%) ^‡^          99.6              99.3     99.3     99.4    99.5

  *Ramachandran-plot statistics*                                                        

  Outlier (%) ^‡^                           0                 0.6      0.8      0.0     0.4

  Favored (%) ^‡^                           92.2              88.1     82.3     89.0    90.7

  *R.m.s. deviations* ^†,**§**^                                                         

  Bond length (Å)                           0.008             0.006    0.006    0.006   0.009

  Bond angle (°)                            1.064             0.892    0.922    0.848   1.113

  Validation (RNA)                                                                      

  Good sugar puckers (%) ^‡^                99.7              99.8     99.8     99.8    99.8

  Good backbone conformation (%) ^‡^        82.9              84.6     85.0     85.0    82.0
  ----------------------------------------------------------------------------------------------

^\*^from Phenix.

^†^from RSRef.

^§^root-mean-square deviations.

^\#^ RNA backbone suites that fall into recognized rotamer conformations defined by MolProbity.

Pre-termination-like Structure I contains tRNA in the P site with its 3′-CCA end positioned in the peptidyl transferase center ([Figure 1A](#fig1){ref-type="fig"}). Although the tRNA is likely partially or completely deacylated due to the action of RF2, the tRNA and ribosome conformations closely resemble those in pre-termination aminoacyl- and peptidyl-tRNA complexes ([@bib4]; [@bib23]; [@bib47]; [@bib79]). The 30S subunit adopts a conformation similar to crystal structures of non-rotated ribosomes with or without RFs ([@bib47]; [@bib53]; [@bib52]; [@bib54]; [@bib60]; [@bib91]; [@bib104]), and exhibits a slight \~1.5° rotation relative to the 70S•RF2 crystal structure formed with the UGA stop codon ([@bib104]).

RF2 is bound in Structures II to IV ([Figure 1B--D](#fig1){ref-type="fig"}). The 70S intersubunit rotation ranges from \~1.5° in Structure II to \~7.5° in Structure IV ([Table 1](#table1){ref-type="table"}). This nearly full range of rotation is typical of translocation complexes with tRNA ([@bib5]; [@bib6]; [@bib27]; [@bib30]; [@bib49]) and elongation factor G (EF-G) ([@bib13]; [@bib22]; [@bib32]; [@bib37]; [@bib81]; [@bib101]; [@bib109]).

The most well-resolved 3.3 Å resolution Structure II ([Figure 1B](#fig1){ref-type="fig"}) accounts for the largest population of RF2-bound ribosome particles in the sample ([Table 2](#table2){ref-type="table"}), consistent with stabilization of the non-rotated 30S states by RF2 observed in FRET studies ([@bib19]; [@bib80]; [@bib94]). The overall extended conformation of RF2 resembles that seen in published 70S•RF2 structures ([@bib53]; [@bib104]) with its codon-recognition superdomain (domains 2 and 4; [Figure 1B](#fig1){ref-type="fig"}) bound to the UGA stop codon in the decoding center of the 30S subunit and its catalytic domain 3 inserted into the peptidyl-transferase center.

Structure II features RF2 with a dramatically rearranged catalytic loop, coinciding with the lack of density for the CCA end of the P tRNA. In previous pre- and post-hydrolysis-like structures, the P-tRNA CCA end binds the PTC, and RF2 forms a compact catalytic loop (residues 245--258). In these previous structures, the catalytic ^250^GGQ^252^ motif resides at the tip of a short α-helix, adjacent to the terminal tRNA nucleotide A76 ([Figure 2A](#fig2){ref-type="fig"}, light shades; ([@bib47]; [@bib53]; [@bib60]; [@bib104]). The α-helical region is held in place by A2602 of 23S [r]{.ul}ibosomal RNA (rRNA), which is critical for termination efficiency ([@bib9]; [@bib78]). In Structure II, however, the catalytic loop adopts an extended β-hairpin conformation that reaches \~10 Å deeper into the peptide tunnel ([Figure 2A--B](#fig2){ref-type="fig"}). To accommodate the extended β-hairpin, nucleotides G2505 and U2506 of 23S rRNA are shifted to widen the PTC ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The center of the β-hairpin occupies the position normally held by A76 of P tRNA ([Figure 2A](#fig2){ref-type="fig"}). The lack of density for the CCA moiety thus suggests that the 3′ end of P tRNA is at least partially released from the PTC. Indeed, formation of the β-hairpin and release of the CCA moiety is accompanied by a slight shift in the P-tRNA acceptor arm away from the PTC and by \~160° rotation of nucleotide A2602 to form a Hoogsteen base pair with C1965 at helix 71 of 23S rRNA ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2](#fig2){ref-type="fig"}[Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The cryo-EM map shows strong density for the extended β strands ([Figure 2C](#fig2){ref-type="fig"}), but weaker density for the GGQ residues at the tip of the hairpin, consistent with conformational heterogeneity of the flexible glycine backbone ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Nevertheless, the tip of the β-hairpin plugs the narrowest region of the peptide tunnel at A2062 of 23S rRNA ([Figure 2B](#fig2){ref-type="fig"}). Thus, Structure II appears to represent a previously unseen post-peptide-release state with deacyl-tRNA dissociating from the PTC.

![Rearrangement of the catalytic domain of RF2 upon tRNA displacement from the PTC.\
(**A**) Rearrangements of RF2 in Structure II (RF2 in red, P-tRNA in orange and 23S in cyan) in comparison with the canonical 70S•RF2 conformation (X-ray structure: [@bib53]; RF2 in pink, P-tRNA in light orange, 23S in gray). Arrows show rearrangements for RF2 (red), tRNA acceptor arm and 23S nucleotide A2602 (black). The superposition was achieved by structural alignment of 23S rRNA. (**B**) The GGQ region of RF2 forms a long β-hairpin that reaches into the constriction of the peptide tunnel (at A2062) and thus plugs the tunnel. Nucleotides of 23S rRNA and the GGQ motif are labeled. (**C**) Cryo-EM density for the β-hairpin formed by the GGQ region. Residues of RF2 and 23S rRNA (also shown in panel B for reference) are labeled.](elife-46850-fig2){#fig2}

In Structure III ([Figure 1C](#fig1){ref-type="fig"}), a 5° rotation of the 30S subunit shifts the tRNA elbow by \~10 Å along protein L5 toward the E site. As a result, the P-tRNA acceptor arm pulls further out of the 50S P site, and the end of the acceptor arm helix points at helix α7 of RF2 near positively charged Lys 282 and Lys 289. The CCA moiety remains unresolved. The 5° intersubunit rotation also causes a slight 2° rotation of RF2 domain 3 relative to domain 2, but the overall conformation of RF2 remains similar to that in Structure II, with the tip of the extended β-hairpin plugging the peptide exit tunnel.

In Structure IV, the 30S subunit is rotated 7.5° and the P-tRNA elbow is bound to the L1 stalk, an interaction normally observed with the P/E or E tRNA ([@bib27]; [@bib52]; [@bib91]). Unlike P/E tRNA, however, the acceptor arm is oriented between the 50S P and E sites ([Figure 1D](#fig1){ref-type="fig"}), suggesting that the tRNA adopts a transient state on its way toward the hybrid P/E conformation. This transition coincides with an \~3° rotation (swivel) of the 30S head, characteristic of intermediate stages of tRNA and mRNA translocation ([@bib1]; [@bib83]). The codon-recognition superdomain of RF2 in its canonical conformation moves with the 30S subunit, causing the catalytic domain to shift by \~5 Å from its position in Structure II ([Figure 3A](#fig3){ref-type="fig"}). Indeed, reduced density for the catalytic domain and domain 1, which bridges the 30S and 50S subunits at the A site periphery ([Figure 1B](#fig1){ref-type="fig"}), suggests that intersubunit rotation has destabilized RF2. In Structure IV, therefore, RF2 appears to be poised for dissociation and collapsing toward the compact conformation adopted by free RFs ([Figure 3A](#fig3){ref-type="fig"}) ([@bib46]; [@bib93]; [@bib103]; [@bib110]).

![Differences in conformations of RF2 and helix 69 of 23S rRNA in Structures II, IV and V.\
(**A**) RF2 in Structures II (red) and IV (blue) in comparison with the crystal structure of isolated (free) RF2 (green, PDB 1GQE \[[@bib103]\]). The arrow shows the direction of domain three repositioning from Structure II to IV to free RF2. Structures were aligned by superposition of domain 2. (**B**) Interactions of H69 (teal) with the switch loop (pink surface) of RF2 in Structure II (RF2 in red, P-tRNA in orange, 50S in cyan and 30S in yellow). Domains 2 and 3 of RF2, head and body domains of the 30S subunit and nucleotides A1913 (at H69) and C1054 (head) are labeled. (**C**) In Structure V, dissociation of H69 from the decoding center and packing on H71 next to A2602 disassembles intersubunit bridge B2a. The structure is colored as in panel B. View in panels B and C is rotated by \~180° relative to panel **A**.](elife-46850-fig3){#fig3}

Structure V is incompatible with RF2 binding and provides further insights into RF2 dissociation. The rotated 70S•tRNA structure resembles hybrid P/E states, with the acceptor arm of tRNA directed toward the E site of 50S ([Figure 1E](#fig1){ref-type="fig"}). However, the central intersubunit bridge B2a---formed by helix 69 (H69, nt. 1906--1924) of 23S rRNA---is disassembled ([Figure 3B--C](#fig3){ref-type="fig"}). In RF-bound structures (including Structures I to IV, above), the tip of H69 (at nt 1913) locks into the decoding center in a termination-specific arrangement ([@bib53]; [@bib54]; [@bib60]; [@bib104]). H69 interacts with the switch loop of RFs, where the codon-recognition superdomain connects to catalytic domain 3 (e.g., Structure II, [Figure 3B](#fig3){ref-type="fig"}). This interaction directs the catalytic domain toward the PTC ([@bib54]; [@bib60]) and thus defines the efficiency and accuracy of release factors ([@bib98]). In Structure V, however, H69 is disengaged from the decoding center and moved \~15 Å toward the large subunit to pack against H71 near A2602 (nt 1945--1961; [Figure 3C](#fig3){ref-type="fig"}). The new position of H69 would clash with extended or compact conformations of RF2 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), if the release factor had remained bound to the decoding center.

Release of RF2 also appears to be coupled to rotation (swivel) of the 30S head domain. In RF2-bound structures, the conserved codon-recognition ^205^SPF^207^ motif (serine-proline-phenylalanine of domain 2) of RF2 interacts with the stop codon and the 30S head near bulged nucleotide C1054 of 16S rRNA. In Structure V, a 6° rotation of the 30S head shifts the position of C1054 by 5 Å from its position in RF2-bound Structure IV, consistent with disassembly of RF2 contacts. The disruption of decoding-center interactions due to repositioning of H69 and head swivel therefore explain the absence of RF2 in Structure V.

Mechanism of translation termination by RF2 {#s2-1}
-------------------------------------------

Our termination structures allow us to reconstruct a dynamic pathway for termination ([Figure 4](#fig4){ref-type="fig"} and [Animation 1](#video1){ref-type="video"}) and reconcile biophysical and biochemical findings ([@bib4]; [@bib19]; [@bib80]; [@bib94]). Recent structural studies revealed compact RF conformations on non-rotated 70S ribosomes ([@bib35]; [@bib98]) that suggest how RFs open at early stages of codon recognition ([@bib41]; [@bib42]; [@bib102]). The short-lived transition from compact to open conformation(s) lasts tens of milliseconds ([@bib35]), and compact RF2 conformations were not captured in our sample. Compact RF2 was also visualized by cryo-EM on the 70S ribosome in the presence of truncated mRNA and alternative rescue factor A (ArfA) ([@bib25]; [@bib45]), suggesting a conserved pathway for initial binding of RFs to non-rotated ribosomes. Together with these recent studies, our work provides an expanded structural view of the termination reaction -- from initial codon recognition to peptide release to RF2 dissociation ([Figure 4](#fig4){ref-type="fig"}).

![Scheme of the termination mechanism.](elife-46850-fig4){#fig4}

###### An animation showing transitions between the structures of the 70S ribosome upon interaction with RF2.

10.7554/eLife.46850.015

Termination begins when release factor recognizes a stop codon in the A site of a non-rotated (or slightly rotated) 70S ribosome carrying peptidyl-tRNA ([Figure 4A](#fig4){ref-type="fig"}). A compact release factor recognizes the stop codon, while its catalytic domain is kept 60 to 70 Å away from the PTC ([@bib35]). Separation of the codon-recognition and catalytic functions during initial binding of RF underlies high accuracy of termination ([@bib41]; [@bib60]; [@bib98]; [@bib102]). Upon binding the decoding center, steric hindrance with P-tRNA forces the RF catalytic domain to undock from domain two and sample the intersubnit space ([Figure 4B](#fig4){ref-type="fig"}) (discussed in [@bib98]). The ribosome remains non-rotated because peptidyl-tRNA bridges the P sites of 30S and 50S subunits. Interactions between the switch loop of RF and the decoding center and H69 direct the catalytic domain into the PTC. The GGQ catalytic loop is placed next to the scissile ester bond of peptidyl-tRNA and stabilized by A2602 ([@bib47]; [@bib60]), so that the Gln backbone amide of the GGQ motif can catalyze peptidyl-tRNA hydrolysis ([Figure 4C](#fig4){ref-type="fig"}) ([@bib53]; [@bib87]). These ribosome and RF2 rearrangements complete the first stage of termination leading to peptidyl-tRNA hydrolysis---an irreversible step that separates the newly made protein from P-site tRNA and prevents further elongation.

To be recycled, the ribosome must release the nascent protein and RF. The deacylated CCA end of the tRNA exits the 50S P site, which allows movement of A2602. No longer stabilized by the tRNA and A2602, the GGQ loop reorganizes into an extended β-hairpin that blocks the peptide tunnel (Structure II), thus biasing the diffusion of nascent peptide toward the exit of the peptide tunnel at the surface of the 50S subunit ([Figure 4D](#fig4){ref-type="fig"}). Furthermore, the exit of the CCA end from the P site supports formation of the P/E-tRNA hybrid conformation via spontaneous intersubunit rotation (Structures III and IV), which is also essential for translocation of tRNA-mRNA (reviewed in [@bib62]; [@bib71]). The large counter-clockwise rotation of the small subunit destabilizes the catalytic domain of RF2 (Structure IV), so that it begins to collapse toward domain 2 bound to the 30S subunit ([Figure 4E](#fig4){ref-type="fig"}). Rotation of the 30S head and detachment of H69 from the decoding center force dissociation of RF2 from the A site of the 30S subunit (Structure V, [Figure 4F](#fig4){ref-type="fig"}).

Remarkably similar extents of intersubunit rotation and head rotation were observed in recent RF1-bound 70S structures formed with RF3•GDPNP in the presence of apidaecin (which stalls RF1 on the ribosome). In the presence of stalled RF1, however, the intersubunit bridge remains attached to the decoding center ([@bib38]). Thus, the ribosome samples globally similar rotation states with RF1 and RF2, with or without RF3. RF3 stabilizes the rotated state ([@bib29]; [@bib36]; [@bib48]; [@bib108]) to promote RF release. However, the role of RF3 in termination is dispensable because intersubunit rotation is an inherent--- that is spontaneous and thermally driven---property of the ribosome ([@bib23]). Cold sensitivity of RF3-deletion strains ([@bib70]; [@bib72]) perhaps manifests the dependence on RF3 due to perturbation of the intersubunit dynamics at lower temperatures. In the fully rotated state, the post-termination ribosome becomes a substrate for subunit dissociation by EF-G and recycling factor RRF ([@bib8]; [@bib27]; [@bib34]; [@bib80]). Structure V is consistent with structural studies showing ribosome recycling factor (RRF) bound to ribosomes with a dislodged intersubunit bridge B2a ([@bib10]; [@bib73]), which helps split the ribosome into subunits. Translation termination and recycling of the release factors and the ribosome therefore rely on the spontaneous ribosome dynamics ([@bib4]; [@bib23]; [@bib29]; [@bib80]; [@bib94]), coupled with local rearrangements of the universally conserved elements of the peptidyl-transferase and decoding centers.

Materials and methods {#s3}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                    Designation                                   Source or reference      Identifiers                                                           Additional\
  (species) or resource                                                                                                                                                                         information
  ------------------------------------------------ --------------------------------------------- ------------------------ --------------------------------------------------------------------- -------------
  Strain, strain background (*Escherichia coli*)   *Escherichia coli* MRE600                     ([@bib16])               ATCC 29417                                                            

  Strain, strain background (*Escherichia coli*)   *Escherichia coli* BLR (DE3)                  Novagen                                                                                        

  Recombinant protein                              C-terminally His-tagged K-12 *E. coli* RF2    ([@bib25])                                                                                     

  Recombinant DNA reagent                          *E. coli* RF2 plasmid (vector pET24b)         ([@bib25])                                                                                     

  Chemical compound, drug                          *E. coli* tRNA^fMet^                          Chemical Block                                                                                 

  Chemical compound, drug                          \[^35^S\]-methionine                          Perkin Elmer             NEG709A500UC                                                          

  Chemical compound, drug                          Biodegradable Scintillation Cocktail          Econo-Safe                                                                                     

  Sequence-based reagent                           RNA GGCAAGGAGGUAAAAAUGUGAAAAAAA               IDT                                                                                            

  Software, algorithm                              PHENIX                                        ([@bib2])                <https://www.phenix-online.org/>                                      

  Software, algorithm                              CNS                                           ([@bib15])               <http://cns-online.org/v1.2/>                                         

  Software, algorithm                              PyMOL                                         ([@bib24])               <https://pymol.org/2/>                                                

  Software, algorithm                              Chimera                                       ([@bib76])               <https://www.cgl.ucsf.edu/chimera/>                                   

  Software, algorithm                              Bsoft                                         ([@bib43])               <https://lsbr.niams.nih.gov/bsoft/>                                   

  Software, algorithm                              Frealign                                      ([@bib65])               [http://grigoriefflab.](http://grigoriefflab.janelia.org/frealign)\   
                                                                                                                          [janelia.org/frealign](http://grigoriefflab.janelia.org/frealign)     

  Software, algorithm                              cisTEM                                        ([@bib39])               <https://cistem.org/>                                                 

  Software, algorithm                              MolProbity                                    ([@bib21])               <http://molprobity.biochem.duke.edu/>                                 

  Software, algorithm                              RSRef                                         ([@bib20]; [@bib51])     <http://www.sb.fsu.edu/~rsref/>                                       

  Software, algorithm                              SerialEM                                      ([@bib66])               <http://bio3d.colorado.edu/SerialEM/>                                 

  Other                                            Holey-carbon grids QUANTIFOIL R 2/1, Cu 200   Quantifoil Micro Tools                                                                         

  Other                                            Vitrobot MK4                                  FEI                                                                                            

  Other                                            Titan Krios microscope                        FEI                                                                                            

  Other                                            K2 Summit camera                              Gatan                                                                                          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Preparation of the 70S termination complex with RF2 {#s3-1}
---------------------------------------------------

N-terminally His6-tagged release factor 2 (RF2) from *E. coli* K12 strain was overexpressed in *E. Coli* BLR (DE3) (Novagen) and purified as described for RF1 ([@bib98]). Due to overexpression, RF2 is likely incompletely methylated (or unmethylated) at Q252 of the catalytic GGQ motif ([@bib26]), which together with the K12-specific T246 residue, renders RF2 catalytically slower ([@bib26]), yet functionally and structurally similar to the post-translationally modified release factors ([@bib53]; [@bib77]; [@bib104]; [@bib107]). *E. coli* tRNA^fMet^ (Chemical Block) was aminoacylated as described ([@bib59]). 70S ribosomes were prepared from *E. coli* (MRE600) as described ([@bib98]). Ribosomes were stored in the ribosome-storage buffer (20 mM Tris-HCl, pH 7.0; 100 mM NH~4~Cl; 12.5 mM MgCl~2~; 0.5 mM EDTA; 6 mM β-mercaptoethanol) at --80°C. A model mRNA fragment, containing the Shine-Dalgarno sequence and a spacer to position the AUG codon in the P site and the UGA stop codon in the A site (GGC AAG GAG GUA AAA [AUG UGA]{.ul} AAAAAA), was synthesized by IDT.

The 70S•mRNA•fMet-tRNA^fMet^ complex with RF2 was assembled in vitro by mixing 400 nM 70S ribosome (all concentrations are specified for the final pre-termination solution) with 12 µM mRNA in buffer containing 20 mM Tris-acetate (pH 7.0), 100 mM NH~4~OAc, 15 mM Mg(OAc)~2~. After incubation for two minutes at 37°C, 600 nM fMet-tRNA^fMet^ was added and incubated for five minutes at 37°C. The Mg(OAc)~2~ concentration was adjusted to 10 mM by adding an equal volume of buffer (20 mM Tris-acetate (pH 7.0), 100 mM NH~4~OAc, 5 mM Mg(OAc)~2~) at room temperature. The release reaction was started by adding an equal volume of 4 µM RF2 (in 20 mM Tris, 100 mM NH~4~OAc, 10 mM Mg(OAc)~2~) to the pre-termination solution, yielding the following final concentrations: 0.2 µM 70S, 6 µM mRNA, 0.3 µM fMet-tRNA^fMet^, and 2 µM RF2. The solution was incubated for 30 min at room temperature prior to grid preparation and plunging.

The activity of *E. coli* RF2 was tested in an in vitro assay that measures the release of formyl-methionine from the 70S ribosome bound with \[^35^S\]-fMet-tRNA^fMet^ in the P site, as described ([@bib98]). Pre-termination complex was prepared using 0.2 µM *E. coli* 70S ribosomes (all concentrations are for the final reaction mixture upon initiation of the release reaction), 6 µM mRNA and 0.3 µM \[^35^S\]-fMet-tRNA^fMet^ (\[^35^S\]-methionine from Perkin Elmer). An aliquot (4.5 μl) of the pre-termination complex was quenched in 30 μl of 0.1 M HCl to represent the zero-time point. Pre-termination complex was split into two tubes. 5 µl of 20 µM RF2 was added to 45 μl of the pre-termination complex in one tube, yielding 2 µM RF2 in the reaction. Buffer without RF2 was added to the second tube to test spontaneous (RF2-independent) hydrolysis of \[^35^S\]-fMet-tRNA^fMet^. After 6, 15, 90 s, and 6, 15, 30, 60 and 150 min, 5 μl aliquots were quenched in 30 μl of 0.1 M HCl. Samples were extracted with ethylacetate, and the amount of released \[^35^S\]-labeled N-formyl-methionine was measured using a scintillation counter (Beckman Coulter, Inc) in 3.5 ml of Econo-Safe scintillation cocktail (RPI). All measurements were performed twice ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}) and time progress data were analyzed and visualized using GraphPad Prizm 7.01.

Cryo-EM and image processing {#s3-2}
----------------------------

Holey-carbon grids (QUANTIFOIL R 2/1, Cu 200, Quantifoil Micro Tools) were coated with carbon and glow discharged with 20 mA with negative polarity for 60 s in a PELCO easiGlow glow discharge unit. 2.8 μl of the 70S•mRNA•fMet-tRNA^fMet^•RF2 complex was applied to the grids. Grids were blotted at blotting force 10 for 4 s at room temperature, 100% humidity, and plunged into liquid ethane using a Vitrobot MK4 (FEI). Grids were stored in liquid nitrogen.

A dataset of 1,069,908 particles was collected on a Titan Krios (FEI) microscope (operating at 300 kV) equipped with a K2 Summit camera system (Gatan), with --0.5 to --1.8 μm defocus. Multi-shot data collection was performed by recording six exposures per hole, using SerialEM ([@bib66]) with beam-image shift. Coma-free alignment was performed using a built-in function. 'Coma vs. Image Shift' from the Calibration menu was used for dynamic beam-tilt compensation, based on image shifts for each exposure. Multi-hole/multi-shot configuration was selected from 'Multiple Record Setup Dialog' to dynamically adjust the beam tilt. Backlash-corrected compensation was applied to each stage movement at the target stage position to reduce mechanical stage drift. 7287 movies were collected. Each exposure (32 frames per movie) was acquired with continuous frame streaming, yielding a total dose of 29.4 e^-^/Å^2^. The nominal magnification was 105,000 and the calibrated super-resolution pixel size at the specimen level was 0.667 Å. 6972 movies were selected after discarding those with defects due to ice or image recording. Movies were processed using IMOD ([@bib57]) and binned to pixel size 1.334 Å (termed unbinned or 1 × binned). Movies were motion-corrected, and frame averages were calculated using all 32 frames within each movie ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), after multiplying by the corresponding gain reference. cisTEM ([@bib39]) was used to determine defocus values for each resulting frame average and for particle picking. The stack and particle parameter files were assembled in cisTEM with the binnings of 1×, 2×, 4×, and 6× (box size of 624 for a non-binned stack).

Data were processed essentially as described in our recent work ([@bib63]) and shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. FrealignX was used for particle alignment, refinement, and final reconstruction steps, and Frealign v9.11 was used for 3D classification steps ([@bib65]). The 6×-binned image stack (1,069,908 particles) was initially aligned to a ribosome reference without release factor and tRNA (PDB 5J4D) ([@bib96]) using 3 cycles of mode 3 (global search) alignment, including data from 20 Å to 300 Å resolution. Subsequently, the 6×-binned stack was refined using mode 1 (3 cycles) to align particles in the 15- to 300 Å resolution range. Using the 4×-binned image stack, the particles were successively refined using mode one by gradually increasing the high-resolution limit to 12- and 10 Å (three cycles for each resolution limit). 3D density reconstruction was obtained using 60% of particles with highest scores. The map contained density for the P-tRNA, mRNA, and RF2.

Data classification was performed using a spherical focused mask with a 45 Å radius, centered roughly between the A-site finger (nucleotides 870--910 of 23S rRNA), protein L11, and peptidyl transferase center. The mask covered most of the ribosomal A site and part of the P site. The particle stack was classified into 16 classes, using the high-resolution limit of 10 Å. The classification resulted in five RF2-containing classes, six classes with tRNA alone (two classes represented Structures I and V), three classes of the 70S ribosome without tRNA, and two classes of the 50S subunit alone. All classes were subsequently reconstructed using the unbinned stack. Three strongest classes with RF2 were merged and extracted from the unbinned stack, and subclassified into 10 classes without masking, using a high-resolution limit of 8 Å. This classification yielded Structure II, four maps that were merged to obtain Structure III, a map with a rotated 70S•RF2 conformation (used for further classification to obtain Structure IV), a lower-resolution map similar to Structure II, and three junk (poorly resolved) classes. The class corresponding to the rotated 70S•RF2 conformation was extracted from the unbinned substack and further classified into three classes using a 25 Å radius spherical-focused mask roughly centered at the elbow of tRNA (high-resolution limit at 12 Å), yielding Structure IV. All final classes were reconstructed in FrealignX (1×-binning) using 95% of particles with highest scores.

The resulting reconstructions varied from 3.3 Å (Structure II) to 4.4 (Structure IV) Å average resolution (Fourier Shell Correlation (FSC) = 0.143). Cryo-EM reconstructions were B-factor sharpened in bfactor.exe (part of Frealign distribution) using different B-factor values (suggested by bfactor.exe) and then used for model building and structure refinements. B-factor from −50 to −100 Å^2^ was also used for initial refinements and to visualize higher-resolution details. FSC curves were calculated by FrealignX for even and odd particle half-sets ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). FSC between the final models and maps, self and cross-validation FSC ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) calculated using Phenix ([@bib3]) demonstrate good overall agreement between the structural models and maps, similarly to those in previous work ([@bib14]). Blocres (part of Bsoft package v1.9.1; [@bib43]) was used to calculate local-resolution maps ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

Model building and refinement {#s3-3}
-----------------------------

Cryo-EM structures of *E. coli* 70S•ArfA•RF2 complex ([@bib25]) excluding ArfA, and the 70S•fMet-tRNA^fmet^ complex with EF-Tu ternary complex ([@bib63]) and improved structure of S2 ([@bib64]), excluding the ternary complex, were used to create initial models for structure refinement. Chimera ([@bib76]) was used for fitting the 50S subunit, 30S head, 30S body, mRNA, tRNA, and RF2 domains. Local model fitting was performed in PyMOL ([@bib24]).

Each structural model was refined by real-space simulated-annealing refinement using atomic electron scattering factors in RSRef, as described ([@bib95]) ([@bib20]; [@bib51]). Secondary-structure restraints, comprising hydrogen-bonding restraints for ribosomal proteins and base-pairing restraints for RNA molecules, were employed as described ([@bib53]). Refinement parameters, such as the relative weighting of stereochemical restraints and experimental energy term, were optimized to produce the stereochemically optimal models that closely agree with the corresponding maps. In the final stage, the structures were refined using Phenix (phenix.real_space_refine) ([@bib3]), followed by a round of refinement in RSRef, applying harmonic restraints to preserve protein backbone geometry. B-factors were refined in Phenix. The refined structural models closely agree with the corresponding maps and have good stereochemical parameters, characterized by low deviation from ideal bond lengths and angles, low numbers of protein-backbone outliers and other robust structure-quality statistics, as shown in [Table 2](#table2){ref-type="table"}. Structure quality was validated using MolProbity ([@bib21]).

Structure superpositions were performed in PyMOL. For structural comparisons, the distances and angles were calculated in PyMOL and Chimera, respectively. To calculate an angle of the 30S subunit rotation between two 70S structures, the 23S rRNAs were aligned using PyMOL, and the angle between 16S rRNAs body domains (all nucleotide residues excluding 925--1390) was measured in Chimera. To calculate an angle of the 30S-head rotation (swivel) between two 70S structures, the 16S rRNAs of the 30S body were aligned using PyMOL, and the angle between the 16S rRNA residues 925--1390 was measured in Chimera. Ribosome conformations (30S body/subunit rotation and 30S head rotation) for Structures I through V were compared with the crystal structure of the 70S•RF2 complex formed with the UGA stop codon ([@bib104]).

Unsharpened cryo-EM maps (direct output from Frealign) were deposited in EMDB (Structure I -- EMD-20048, Structure II -- EMD-20052, Structure III -- EMD-20056, Structure IV -- EMD-20057, Structure V -- EMD-20058). The corresponding PDB models were deposited in RCSB (PDB codes: 6OFX, 6OG7, 6OGF, 6OGG, 6OGI respectively). Figures were prepared in PyMOL.
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SvidritskiyEDemoGLovelandABXuCKorostelevAA2019Non-rotated ribosome (Structure I)Protein Data Bank6OFX

SvidritskiyEDemoGLovelandABXuCKorostelevAA2019Non-rotated ribosome (Structure I)Electron Microscopy Data BankEMD-20048

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Non-rotated ribosome with RF2 bound (Structure II)Protein Data Bank6OG7

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Partially rotated ribosome with RF2 bound (Structure III)Protein Data Bank6OGF

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with the UGA stop codon. Rotated ribosome conformation (Structure V)Protein Data Bank6OGI

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Rotated ribosome with RF2 bound (Structure IV)Protein Data Bank6OGG

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Non-rotated ribosome with RF2 bound (Structure II)Electron Microscopy Data BankEMD-20052

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Partially rotated ribosome with RF2 bound (Structure III)Electron Microscopy Data BankEMD-20056

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with RF2 bound to the UGA codon. Rotated ribosome with RF2 bound (Structure IV)Electron Microscopy Data BankEMD-20057

SvidritskiyEDemoGLovelandABXuCKorostelevAA201970S termination complex with the UGA stop codon. Rotated ribosome conformation (Structure V)Electron Microscopy Data BankEMD-20058
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Extensive ribosome and RF2 rearrangements during translation termination\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Sjors HW Scheres as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by John Kuriyan as the Senior Editor. The following individual involved in review of your submission has also agreed to reveal their identity: Israel S Fernández (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper describes five cryo-EM structures of ribosomal complexes apparently representing different stages of RF2-catalyzed translation termination. The novel observations here are that the tip of domain 3 of RF2 undergoes a rearrangement from an a-helical conformation to a b-hairpin conformation during termination that likely facilitates exit of the newly synthesized protein from the ribosomal polypeptide exit tunnel and that the ribosome can undergo two thermally activated, spontaneous conformational changes, a relative rotation of the ribosomal subunits and a swiveling of the \'head\' domain of the small subunit, during termination that likely facilitate dissociation of RF2 from the ribosome. These are interesting observations that significantly extend our understanding of how class I RFs and ribosome conformational changes drive important steps during termination and, as such, all three reviewers recommended publication provided the following comments are addressed adequately.

Essential revisions:

1\) The maps provided through the *eLife* system seemed to be unsharpened, as they showed very little detail. However, even after sharpening them with a B-factor of -100A2, they still did not show the expected features for their respective resolutions. My suspicion is that FREALIGN has been used to overfit the data. This should be addressed in the revision. It should be indicated whether gold-standard separation of halves of the data sets were used in the final refinements, or whether those were limited to a specific spatial frequency (like was done in the classifications). If the latter, those frequencies should also be stated in the manuscript, and they should be significantly lower than the claimed resolutions.

In addition: a lot of basic cryo-EM information is missing: the authors should include:

a\) At least one micrograph image.

b\) Some representative 2D class averages.

c\) Local resolution maps of the five structures. Also, because the density of important parts of the maps seems to be a lot worse than the resolution claimed, it would be good to explicitly mention the local resolution of the important features discussed in the main text.

d\) For each structure, some zoomed-in figures with the density on top of the molecular model. These figures should be chosen as to validate the resolution claim. For example, in structures I, II and V, the RNA bases should be well separated (they do so at 3.6A), and in structures III and IV β-strands should be well separated, and many (larger) side chains should be visible. In addition, some panels with density for the most important features of each structure should be shown.

e\) FSC curves between the refined PDB models and the cryo-EM maps are missing from the manuscript. These should be included. In addition, to evaluate potential overfitting of the models in the maps, for each structure, the authors should also include the FSC curves between a model that was refined in half-map1 versus half-map1, as well as the FSC curve between the same model versus half-map2.

2\) There appear to be many self-citations, and there are also a few places where relevant citations are missing or are mis-cited. There are too many to list individually, but, just a few examples: Introduction: the only citation for the phrase \"recent biophysical and biochemical findings suggest a highly dynamic series of termination events\" is a Rodnina paper. There are many, earlier papers from Ehrenberg, Gonzalez, Puglisi, Green, Joseph, etc. that should be cited here. Introduction: The only citation for the sentence \"By contrast, biochemical experiments showed...\" is a Green paper. There are earlier papers from Ehrenberg characterizing the effects of the GGQ\--\>GAQ mutations on the ability of RF3 to accelerate the dissociation of class I RFs from termination complexes that should be cited here. Introduction: There\'s a sentence that refers to X-ray, cryo-EM, and smFRET studies, but only provides citations to two smFRET studies (Casy et al., 2018 and Sternberg et al., 2009); Introduction: Moazed and Noller, 1989 identified and characterized the P/E hybrid state, but they didn\'t report that a deacylated P-site tRNA \'samples\' the P/E hybrid state \'via a spontaneous intersubunit rotation\'\--that was later work from Noller and Ha; etc. There are several other instances of missing citations or mis-citations. We would ask that the authors review their citations with an eye for excessive self-citations and for missing citations or mis-citations. In this context, \"Ensemble-EM\" is also cited as a specific method in the Introduction (Abeyrathne et al., 2016; Loveland et al., 2017). However, this method is more commonly known as (3D) classification of cryo-EM images, and there are many older, more appropriate citations.

3\) The sample imaged is a model sample generated by in vitro assembly with purified components of a termination complex. In order to mimic a bona fide termination complex, a short messenger RNA with a strong Shine-Dalgarno sequence followed by a start codon and immediately after by a stop codon was used (mRNA sequence: 5\'-GGC AAG GAG GUA AAA AUG UGA AAAAAA-3\'). Similar constructs were used to crystallize termination complexes in the past and it has been proven by smFRET experiments that, at least regarding ribosomal inter-subunit dynamics, this model sample behaves similarly to a real termination complex with a peptide linked to the P site tRNA. However, the nature of this model sample should be apparent for the non-specialist reader, highlighting its similarities with a real termination complex but also its possible limitations, especially regarding the \"artificial\" nature of having a stop codon so close to the Shine-Dalgarno sequence, a situation that never happens in real mRNAs. The authors should explicitly acknowledge this and discuss its implications in the main text.

4\) The authors set up a couple of somewhat \'strawman\' arguments in claiming that: (i) there are discrepancies in the X-ray, cryo-EM, and smFRET literature with regard to whether ribosomes can undergo intersubunit rotation while bound to class I RFs or whether the non-rotated conformation of the ribosome is stabilized by bound class I RFs and (ii) class I RFs are able to terminate translation and dissociate from the ribosome without the aid of RF3. In the case of (i), it is obviously possible for class I RF-bound ribosomes to undergo intersubunit rotation while still favoring the non-rotated conformation of the ribosome. Moreover, there are enough differences between the cited studies, both in terms of the experimental conditions as well as the technical limitations associated with the various experimental techniques, that it is easy to rationalize differences with regard to whether the class I RF-bound ribosomes would be expected to undergo intersubunit rotation and/or whether the researchers would have been able to capture/observe intersubunit rotation. In the case of (ii), decades of biochemistry from Buckingham, Ehrenberg, Green, and others had already demonstrated that class I RFs are able to terminate translation and dissociate from the ribosome without the aid of RF3, and that the role of RF3 in termination is to accelerate the spontaneous dissociation of the class I RFs. If the authors want to highlight discrepancies in the literature, they should frame them in the context of differences between the studies, experimental design, limitations of the approaches/techniques in the cited papers that might account for such discrepancies. Re-writing this paragraph also in the light of addressing the missing citations and mis-citations pointed out under (2) will further help in toning these arguments down, which would strengthen the manuscript\'s scholarship.

5\) Class I RFs are post-translationally methylated at the Q residue of the GGQ motif of domain 3 and Buckingham, Ehrenberg, and others have shown that this methylation accelerates and/or facilitates class I-catalyzed termination both in vitro and in vivo. Nonetheless, Svidritskiy et al. do not report whether and to what extent their RF2 is methylated. Was RF2 overexpressed in a manner that ensured homogeneous methylation or lack of methylation? If they are overexpressing prfB and not overexpressing prmC, it is likely that they have a mix of methylated and unmethylated RF2. Assuming they are using the wt *E. coli* prfB gene, then the residue at position 246 is a T, rather than an A or S, and Buckingham has shown that, in the wt T246 background, a lack of methylation at Q252 is either seriously detrimental in richer media or lethal in more minimal media. It was felt that a discussion of this issue was not needed in the main text, but that it would be helpful if the authors would include the important/relevant experimental details in the Materials and methods section, for example, did they use the T246 wt *E. coli* variant of RF2; and did they overexpress prmC along with prfB?

6\) Structure I is denoted and treated as a pre-termination complex, but that does not seem at all possible given that the sample was prepared by incubating a pre-termination complex for 30 min in the presence of excess RF2, conditions that Figure 1---figure supplement 3 suggest results in robust termination. Structure I is more likely the non-rotated conformation of a post-termination complex that is in equilibrium with its rotated counterpart, Structure V. Based on my reading of the manuscript, it is likely that the authors understand this point, but are nonetheless using this structure as a mimic/analog of a pre-termination complex. If so, I think this is fine, but the authors should explicitly state that this is what they are doing. Related to this, the authors should clarify the description of their activity assay, show the raw data, and/or report \'Released \[S35\]-fMet (%)\' instead of \'Released \[S35\]-fMet, CPM\' on the y-axis of Figure 1---figure supplement 3; as the activity assay is currently described, reported, and plotted, it is impossible to determine whether RF2 is 1% or 99% active in termination.

7\) The final sentence of the manuscript reads: \"Translation termination and recycling of the release factors and the ribosome therefore rely on the spontaneous ribosome dynamics, triggered by local rearrangements of the universally conserved elements of the peptidyl-transferase and decoding centers\". There are a couple of problems with this sentence as written. First, smFRET experiments by Gonzalez, Puglisi, and Rodnina have previously shown that \"Translation termination and recycling of the release factors and the ribosome therefore rely on the spontaneous ribosome dynamics\" and the relevant articles should therefore be cited here. Moreover, given the data are static structures solved using a sample that is at equilibrium, it is not clear how the authors determined that these spontaneous ribosome dynamics were \"triggered by local rearrangements of the universally conserved elements of the peptidyl-transferase and decoding centers\". Isn\'t it equally possible, given the data presented, that the local rearrangements were triggered by the ribosome dynamics?

10.7554/eLife.46850.039

Author response

> Essential revisions:
>
> 1\) The maps provided through the eLife system seemed to be unsharpened, as they showed very little detail. However, even after sharpening them with a B-factor of -100A2, they still did not show the expected features for their respective resolutions. My suspicion is that FREALIGN has been used to overfit the data. This should be addressed in the revision. It should be indicated whether gold-standard separation of halves of the data sets were used in the final refinements, or whether those were limited to a specific spatial frequency (like was done in the classifications). If the latter, those frequencies should also be stated in the manuscript, and they should be significantly lower than the claimed resolutions.

Thank you for pointing out. To exclude high-resolution bias, we have limited the resolution to 12, 10 or 8 Å during different stages of classification, which are significantly lower than the high resolution of the resulting maps (3 to 4 Å). Thus map details that resolve the structure at a substantially higher resolution than 8 Å originate from the data, and cannot be the result of overfitting. We provide this information in Materials and methods. We also specify that the maps have been sharpened by bfactor.exe (part of Frealign distribution) for structural analyses and that unsharpened Frealign maps have been uploaded to EMDB. Also see answers to questions below regarding local resolution and structure/map quality.

> In addition: a lot of basic cryo-EM information is missing: the authors should include:
>
> a\) At least one micrograph image.

A micrograph image is shown in Figure 1---figure supplement 3.

> b\) Some representative 2D class averages.

We have not performed 2D classification in this work, as unsupervised 3D classification has proven sufficient to obtain ribosome maps from our sample preparations, based on our previous studies.

> c\) Local resolution maps of the five structures. Also, because the density of important parts of the maps seems to be a lot worse than the resolution claimed, it would be good to explicitly mention the local resolution of the important features discussed in the main text.

We have calculated local-resolution "heat" maps for each map using Blocres and show them in Figure 1---figure supplement 2 (right panels). These maps support the global resolution assignments of the five maps and show well-resolved local features that we discuss, such as peptidyl-transferase center in most resolved structures, such as Structure II.

> d\) For each structure, some zoomed-in figures with the density on top of the molecular model. These figures should be chosen as to validate the resolution claim. For example, in structures I, II and V, the RNA bases should be well separated (they do so at 3.6A), and in structures III and IV β-strands should be well separated, and many (larger) side chains should be visible. In addition, some panels with density for the most important features of each structure should be shown.

Thank you for this suggestion. Most local features discussed in the manuscript agree reasonably well with local and global resolutions determined at FSC of 0.143 in B-factor sharpened maps, as demonstrated in local views in Figure 2 and Figure 2--- figure supplement 2 (demonstrating density views for the detailed structural features we discuss in the manuscript). As suggested by the reviewer, we now also provide views of local density for each structure (Figure 1---figure supplement 2, middle panels), which illustrate local resolution (e.g. separation of RNA bases and secondary structure) consistent with average resolution -- for each structure.

> e\) FSC curves between the refined PDB models and the cryo-EM maps are missing from the manuscript. These should be included. In addition, to evaluate potential overfitting of the models in the maps, for each structure, the authors should also include the FSC curves between a model that was refined in half-map1 versus half-map1, as well as the FSC curve between the same model versus half-map2.

We have added this information in Materials and methods and Figure 1---figure supplement 2 (left panels), for each structure.

> 2\) There appear to be many self-citations, and there are also a few places where relevant citations are missing or are mis-cited. There are too many to list individually, but, just a few examples: Introduction: the only citation for the phrase \"recent biophysical and biochemical findings suggest a highly dynamic series of termination events\" is a Rodnina paper. There are many, earlier papers from Ehrenberg, Gonzalez, Puglisi, Green, Joseph, etc. that should be cited here. Introduction: The only citation for the sentence \"By contrast, biochemical experiments showed...\" is a Green paper. There are earlier papers from Ehrenberg characterizing the effects of the GGQ\--\>GAQ mutations on the ability of RF3 to accelerate the dissociation of class I RFs from termination complexes that should be cited here. Introduction: There\'s a sentence that refers to X-ray, cryo-EM, and smFRET studies, but only provides citations to two smFRET studies (Casy et al., 2018 and Sternberg et al., 2009); Introduction: Moazed and Noller, 1989 identified and characterized the P/E hybrid state, but they didn\'t report that a deacylated P-site tRNA \'samples\' the P/E hybrid state \'via a spontaneous intersubunit rotation\'\--that was later work from Noller and Ha; etc. There are several other instances of missing citations or mis-citations. We would ask that the authors review their citations with an eye for excessive self-citations and for missing citations or mis-citations. In this context, \"Ensemble-EM\" is also cited as a specific method in the Introduction (Abeyrathne et al., 2016; Loveland et al., 2017). However, this method is more commonly known as (3D) classification of cryo-EM images, and there are many older, more appropriate citations.

Thank you. We have updated the references in the manuscript and have included additional references, as suggested, while trying to minimize self-citations.

> 3\) The sample imaged is a model sample generated by in vitro assembly with purified components of a termination complex. In order to mimic a bona fide termination complex, a short messenger RNA with a strong Shine-Dalgarno sequence followed by a start codon and immediately after by a stop codon was used (mRNA sequence: 5\'-GGC AAG GAG GUA AAA AUG UGA AAAAAA-3\'). Similar constructs were used to crystallize termination complexes in the past and it has been proven by smFRET experiments that, at least regarding ribosomal inter-subunit dynamics, this model sample behaves similarly to a real termination complex with a peptide linked to the P site tRNA. However, the nature of this model sample should be apparent for the non-specialist reader, highlighting its similarities with a real termination complex but also its possible limitations, especially regarding the \"artificial\" nature of having a stop codon so close to the Shine-Dalgarno sequence, a situation that never happens in real mRNAs. The authors should explicitly acknowledge this and discuss its implications in the main text.

Thank you for raising this important point. We have expanded the introductory section of Results to explain that we use a model complex, which differs from a cellular termination complex containing an entire ORF, yet represents a functional complex as demonstrated by numerous independent studies.

> 4\) The authors set up a couple of somewhat \'strawman\' arguments in claiming that: (i) there are discrepancies in the X-ray, cryo-EM, and smFRET literature with regard to whether ribosomes can undergo intersubunit rotation while bound to class I RFs or whether the non-rotated conformation of the ribosome is stabilized by bound class I RFs and (ii) class I RFs are able to terminate translation and dissociate from the ribosome without the aid of RF3. In the case of (i), it is obviously possible for class I RF-bound ribosomes to undergo intersubunit rotation while still favoring the non-rotated conformation of the ribosome. Moreover, there are enough differences between the cited studies, both in terms of the experimental conditions as well as the technical limitations associated with the various experimental techniques, that it is easy to rationalize differences with regard to whether the class I RF-bound ribosomes would be expected to undergo intersubunit rotation and/or whether the researchers would have been able to capture/observe intersubunit rotation. In the case of (ii), decades of biochemistry from Buckingham, Ehrenberg, Green, and others had already demonstrated that class I RFs are able to terminate translation and dissociate from the ribosome without the aid of RF3, and that the role of RF3 in termination is to accelerate the spontaneous dissociation of the class I RFs. If the authors want to highlight discrepancies in the literature, they should frame them in the context of differences between the studies, experimental design, limitations of the approaches/techniques in the cited papers that might account for such discrepancies. Re-writing this paragraph also in the light of addressing the missing citations and mis-citations pointed out under (2) will further help in toning these arguments down, which would strengthen the manuscript\'s scholarship.

We agree that this paragraph could more clearly state the rationale for this work. Instead of focusing on experimental differences among numerous biochemical and biophysical studies, which may have led to different interpretations, results or other discrepancies, we have rewritten the concluding part of this paragraph to make it clear that our goal was to visualize new 70S\*RF2 structures that have been suggested by biophysical studies but have not been structurally characterized.

*5) Class I RFs are post-translationally methylated at the Q residue of the GGQ motif of domain 3 and Buckingham, Ehrenberg, and others have shown that this methylation accelerates and/or facilitates class I-catalyzed termination both* in vitro *and* in vivo*. Nonetheless, Svidritskiy et al. do not report whether and to what extent their RF2 is methylated. Was RF2 overexpressed in a manner that ensured homogeneous methylation or lack of methylation? If they are overexpressing prfB and not overexpressing prmC, it is likely that they have a mix of methylated and unmethylated RF2. Assuming they are using the wt E. coli prfB gene, then the residue at position 246 is a T, rather than an A or S, and Buckingham has shown that, in the wt T246 background, a lack of methylation at Q252 is either seriously detrimental in richer media or lethal in more minimal media. It was felt that a discussion of this issue was not needed in the main text, but that it would be helpful if the authors would include the important/relevant experimental details in the Materials and methods section, for example, did they use the T246 wt E. coli variant of RF2; and did they overexpress prmC along with prfB?*

We now provide this additional information in the experimental section.

> 6\) Structure I is denoted and treated as a pre-termination complex, but that does not seem at all possible given that the sample was prepared by incubating a pre-termination complex for 30 min in the presence of excess RF2, conditions that Figure 1---figure supplement 3 suggest results in robust termination. Structure I is more likely the non-rotated conformation of a post-termination complex that is in equilibrium with its rotated counterpart, Structure V. Based on my reading of the manuscript, it is likely that the authors understand this point, but are nonetheless using this structure as a mimic/analog of a pre-termination complex. If so, I think this is fine, but the authors should explicitly state that this is what they are doing. Related to this, the authors should clarify the description of their activity assay, show the raw data, and/or report \'Released \[S35\]-fMet (%)\' instead of \'Released \[S35\]-fMet, CPM\' on the y-axis of Figure 1---figure supplement 3; as the activity assay is currently described, reported, and plotted, it is impossible to determine whether RF2 is 1% or 99% active in termination.

We agree and we have added a clarification that Structure I is likely deacylated but the ribosome and tRNA are similar to pre-reaction structures. We have also updated the supplementary figure to show the time progress curves with fractions of released fMet instead of CPM (now Figure 1---figure supplement 4).

> 7\) The final sentence of the manuscript reads: \"Translation termination and recycling of the release factors and the ribosome therefore rely on the spontaneous ribosome dynamics, triggered by local rearrangements of the universally conserved elements of the peptidyl-transferase and decoding centers\". There are a couple of problems with this sentence as written. First, smFRET experiments by Gonzalez, Puglisi, and Rodnina have previously shown that \"Translation termination and recycling of the release factors and the ribosome therefore rely on the spontaneous ribosome dynamics\" and the relevant articles should therefore be cited here. Moreover, given the data are static structures solved using a sample that is at equilibrium, it is not clear how the authors determined that these spontaneous ribosome dynamics were \"triggered by local rearrangements of the universally conserved elements of the peptidyl-transferase and decoding centers\". Isn\'t it equally possible, given the data presented, that the local rearrangements were triggered by the ribosome dynamics?

We agree and we have added the references to this section of the manuscript. We have substituted "triggered by" with "coupled with".
